Preclinical Evaluation of In Vitro and In Vivo Antiviral Activities of KCT-01, a New Herbal Formula against Hepatitis B Virus

Hepatitis B virus (HBV) infectious diseases currently remain incurable due to limitations of conventional antivirals such as incapability of eradicating HBV DNA, prolonged use, drug resistance, and virological relapse. KCT-01, a 30% ethanol extract consisting of Artemisia capillaris, Sanguisorba off...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Evid Based Complement Alternat Med
Auteurs principaux: Kim, Hong, Jang, Eungyeong, Kim, So-Young, Choi, Ji-Yoon, Lee, Na-Rae, Kim, Dae-Sung, Lee, Kyung-Tae, Inn, Kyung-Soo, Kim, Bum-Joon, Lee, Jang-Hoon
Format: Artigo
Langue:Inglês
Publié: Hindawi 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6057320/
https://ncbi.nlm.nih.gov/pubmed/30069220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1073509
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires